THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS
- PMID: 21552392
- PMCID: PMC3089005
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS
Abstract
The immunosuppressive effects of FR 900506 were studied in Lewis rats given ACI heterotopic heart allografts. Intramuscular doses of 0.02 mg/kg daily for 2 weeks extended graft survival slightly, and with doses up to 1.28 mg/kg for 2 weeks, there is long-term graft survival. If only 3 daily doses were given starting on day 4 after transplantation, graft survival for almost 3 months was accomplished in 4 of 6 animals who still bear functioning hearts.
References
-
- OCHIAI T, NAKAJIMA K, NAGATA M, SUZUKI T, ASANO T, UEMATSU T, GOTO T, HORI S, KENMOCHI T, NAKAGOORI T, ISONO K. Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Transplant Proc. 1987;19:1284–1286. - PubMed
-
- ONO K, LINDSAY L. Improved techniques of heart transplantation in rats. J Thorac Cardiovasc Surg. 1969;7:225–229. - PubMed
-
- HOMAN WP, FABRE JW, WILLIAMS KA, MILLARD PR, MORRIS PJ. Studies on the immunosuppressive properties of cyclosporin A in rats receiving renal allografts. Transplantation. 1980;29:361–366. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources